Funabashi, Japan

Yoshio Ohara

This inventor holds 19 USPTO granted patents, plus 2 CIPO patents, primarily in Organic Chemistry. Top assignees: Nissan Chemical Industries Limited, Daicel Chemical Industries, Ltd.. Active years: 1983-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshio Ohara. Retrieved from https://idiyas.com/inventor/yoshio-ohara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 89.5


Average Co-Inventor Count = 4.0

ph-index = 5

Forward Citations = 54(Granted Patents)


Location History:

  • Narashino, JP (1986 - 1987)
  • Chiba-ken, JP (1999)
  • Chiba, JP (2002)
  • Funabashi, JP (1983 - 2006)

Company Filing History:


Years Active: 1983-2006

Loading Chart...
Loading Chart...
Areas of Expertise:
Benzopyran Derivatives
Quinoline Compounds
Optically Active
Thiazolidines
Bicyclo Carboxylic Acids
Optical Resolution
Diastereomer Salts
Propionic Acids
Aminoalkoxyborane Complexes
Mevalonolactone Compounds
Phenylpropionic Acid Esters
Intermediate Preparation
19 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Yoshio Ohara

Introduction

Yoshio Ohara, an accomplished inventor based in Funabashi, Japan, has made significant strides in the field of pharmaceuticals. With a remarkable portfolio of 19 patents, Ohara's innovations primarily focus on advancements in antiarrhythmic agents, demonstrating his commitment to enhancing healthcare solutions.

Latest Patents

Ohara's latest inventions include significant advancements in benzopyran derivatives. His first patent revolves around "Substituted benzopyran derivatives against arrhythmia." This invention pertains to specific derivatives characterized by a complex formula, with various substituents offering promise as effective antiarrhythmic agents. The second patent, "4-aminobenzopyran derivatives," similarly explores benzopyran derivatives, detailing intricate chemical configurations aimed at combating arrhythmia. Both compounds have been recognized for their potential therapeutic applications in medicine.

Career Highlights

Throughout his career, Yoshio Ohara has been associated with renowned organizations such as Nissan Chemical Industries Limited and Daicel Chemical Industries, Ltd. His work at these companies contributed to his expertise in chemical innovations, particularly in the pharmaceutical field. Ohara's tireless dedication to research and development has positioned him as a key player in the industry.

Collaborations

In his journey as an inventor, Ohara has collaborated with notable colleagues including Mikio Suzuki and Hiroshi Kashihara. These partnerships have likely facilitated the exchange of valuable insights and expertise, enabling Ohara to bring forth groundbreaking inventions in the realm of benzopyran derivatives.

Conclusion

Yoshio Ohara stands out as a notable inventor whose significant contributions to the pharmaceutical industry underscore his innovative spirit. With a portfolio rich in patents related to antiarrhythmic agents, his work not only reflects his technical prowess but also his commitment to improving human health through scientific advancement. As he continues to innovate, the world can anticipate the positive impact of his inventions on medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…